Navigation Links
TGen's Huentelman and Weiss named to 2013 Class of 40 Under 40
Date:6/5/2013

PHOENIX, Ariz. June 5, 2013 Dr. Matt Huentelman of the Translational Genomics Research Institute (TGen) and Dr. Glen Weiss of TGen and Cancer Treatment Centers of America (CTCA) are among the 40 business leaders under 40 years of age named by the Phoenix Business Journal to its 13th Annual Class of 40 Under 40.

They will be honored at an awards ceremony June 27 at the Phoenix Art Museum.

Dr. Huentelman, Ph.D., is an Associate Professor in TGen's Neurogenomics Division, where he oversees research programs focused on sensory disorders, including hearing and vision loss, and on aging and age-related diseases, such as Alzheimer's disease and the genetics of learning and memory highlighted recently by the launch of TGen's MindCrowd project (http://www.MindCrowd.org).

Dr. Huentelman also is the Co-Director of TGen's Center for Rare Childhood Disorders, which investigates uncommon neurologic problems among children, often those that are only a collection of symptoms with no diagnosis.

"I am honored to be selected among the 40 Under 40 by the Phoenix Business Journal," Dr. Huentelman said. "This recognition serves to highlight the significant advances that TGen has made through the study of the human genome, and the insights and breakthroughs being made, not only by me, but by our entire scientific staff every day."

Dr. Weiss, M.D., is a Clinical Associate Professor in TGen's Cancer and Cell Biology Division and is Director of Clinical Research at CTCA. His research focuses on genomic and other 'omics characterizations of lung cancer, rare cancers and early-detection strategies.

Dr. Weiss has been selected by CTCA at Western Regional Medical Center to head the startup of a new clinical research program in Goodyear, Ariz. Dr. Weiss is also Co-Unit Head of TGen's Lung Cancer Research Laboratory.

"As a research scientist, being a member of the 40 Under 40 is a reflection of the collaborations I am privileged to conduct through TGen and CTCA," Dr. Weiss said. "As a medical doctor, these collaborations lead to new therapies that can help the patients that look to us for healing and hope."

The 40 Under 40 program's hundreds of alumni includes Phoenix Mayor Greg Stanton, a member of the TGen Board of Directors, and Arizona Diamondbacks President Derrick Hall, a member of TGen's National Advisory Council for Pancreatic Cancer Research.


'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Related biology news :

1. LSUHSCs Weiss chosen to help set national eye policy, research
2. Carnegies Greg Asner named Energy/Climate Fellow by US State Department
3. John A. Kaufman named 2012 Dotter Lecturer by Society of Interventional Radiology Foundation
4. Researchers aim to assemble the tree of life for all 2 million named species
5. UMass Medical School scientist named 2012 Pew Latin-American Fellow in the Biomedical Sciences
6. Top young Latin-American scientists named Pew Biomedical Fellows
7. Kendall L. Carder named recipient of the Jerlov Award
8. Winners named in 2012 AAAS Kavli Science Journalism Award Competition
9. Michael Barnett of Boston College named Professor of the Year for Massachusetts
10. Cultural anthropologist Mark Flinn named 2013 AAAS Fellow
11. Kansas State University scientists named American Association for the Advancement of Science fellows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: